Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab-Reference-Cited by-同舟云学术

Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab

Published:2022-11 Issue:11 Volume:10 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Bowens Brendan K.¹,Chou Eva²,LaChance David P.¹³^ORCID,Huynh James R.¹,Voorhees Patrick⁴,Do Thanh C.³,Shakir Mohamed K. M.³⁵^ORCID,Hoang Thanh D.³⁵^ORCID

Affiliation:

1. Department of Medicine Dwight D. Eisenhower Army Medical Center Augusta Georgia USA

2. Department of Ophthalmology Walter Reed National Military Medical Center Bethesda Maryland USA

3. Division of Endocrinology, Department of Medicine Uniformed Service University of the Health Sciences Bethesda Maryland USA

4. Department of Pathology Walter Reed National Military Medical Center Bethesda Maryland USA

5. Division of Endocrinology, Department of Medicine Walter Reed National Military Medical Center Bethesda Maryland USA

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.6621

Reference18 articles.

1. Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves' disease

2. Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement

3. 2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease

4. Pretibial Myxedema

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent pretibial myxedema and thyroid eye disease following mRNA COVID-19 vaccine in a patient with history of Graves’ disease;Annales d'Endocrinologie;2023-10

2. Dermatologic manifestations of thyroid disease: a literature review;Frontiers in Endocrinology;2023-05-12